Superoxide dismutase and oxygen radical neurotoxicity

Current Opinion in Neurology

Volumn 9, Issue 6, 1996, Pages 486-491

  Hosler, Betsy A ^a   Brown Jr , Robert H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; OXYGEN RADICAL; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; ZINC;

AMYOTROPHIC LATERAL SCLEROSIS; CELL PROTECTION; DEGENERATIVE DISEASE; GENE MUTATION; HUMAN; MOTONEURON; MOUSE; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; SHORT SURVEY;

EID: 0030465501     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199612000-00016     Document Type: Short Survey

References (49)

1. 3H]GABA release from cerebral cortical neurons is mediated by peroxynitrite. J Neurochem 1995, 65:1109-1114.
2. Ohkuma S, Katsura M, Guo J-L, Hasegawa T, Kuriyama K: Participation of peroxynitrite in acetylcholine release induced by nitric oxide generators. Neurosci Lett 1995, 183:151-154.
3. Ballard P, Tetrud J, Langston J: Permanent human Parkinson's disease due to 1-methyl-4-phenyl-1,2,5,6-tetra-hydro pyridine (MPTP): seven cases. Neurology 1985, 35:949-956.
4. Przedborski S, Kostic V, Jackson-Lewis V, Naini AB, Simonetti S, Fahn S, Carlson E, Epstein CJ, Cadet JL: Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-pheny-1,2,3,6-tetrahydropyridine induced neurotoxicity. J Neurosci 1992, 12: 1658-1667.
5. Dexter D, Carter C, Wells F, Agid F, Agid Y, Lees A, Jenner P, Marsden C: Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 1989, 52:381-389.
6. Dexter D, Holley A, Flitter W, Slater T, Wells F, Daniel S, Lees A, Jenner P, Marsden C: Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra. Mov Disorders 1994, 9:92-97.
7. Behl C, Davis J, Lesley R, Shubert D: Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 1994, 77:817-827.
8. Mattson M, Goodman Y. Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium. Brain Res 1995, 676:219-224.
9. Brown RH, Jr: Superoxide dismutase in familial amyotrophic lateral sclerosis: models for gain of function. Curr Opin Neurobiol 1995, 5:841-846.
10. Fridovich I: Superoxide radical and superoxide dismutases. Ann Rev Biochem 1995, 64:97-112.
11. 2. They also reported that chelation of copper ameliorated the pro-apoptotic properties of mutant SOD1.
12. Shaw PJ, Ince PG, Falkous G, Mantle D: Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann Neurol 1995, 38:691-695.
13. Abe K, Pan LH, Watanabe M, Kato T, Itoyama Y: Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis. Neurosci Lett 1995, 199:152-154. Inclusions within motor neurons in autopsied tissue from three ALS patients were immunostained with antibodies to nitrotyrosine.
14. Bowling AC, Schulz JB, Brown RHJ, Beal MF: Superoxide dismutase activity, oxidative damage and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 1993, 61:2322-2325.
15. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA: Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide / superoxide in cortical cell cultures. Proc Natl Acad Sci U S A 1995, 92:7162-7166.
16. Manganaro F, Chopra VS, Mydlarski MB, Bernatchez G, Schipper HM: Redox perturbations in cysteamine-stressed astroglia: implications for inclusion formation and gliosis in the aging brain. Free Radical Biol Med 1995, 19:823-835.
17. Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, Nicotera P: Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995, 15:961-973. The authors showed that there is a correlation between levels of mitochondrial function (as assessed by mitochondrial membrane potential) and the occurrence of either apoptotic or necrotic neuronal death following excitotoxicity: in this paradigm, necrotic deaths are seen more commonly in neurons whose mitochondria undergo extensive, irreversible loss of membrane potential.
18. Bergeron C, Petrunka C, Weyer, L: Copper/zinc superoxide dismutase expression in the human central nervous system. Correlation with selective neuronal vulnerability. Am J Pathol 1996, 148:273-279.
19. White E: Life, death, and the pursuit of apoptosis. Genes Devel 1996, 10:1-15.
20. Vaux DL, Strasser A: The molecular biology of apoptosis. Proc Natl Acad Sci U S A 1996, 93:2239-2244.
21. Greenlund LJS, Korsmeyer SJ, Johnson EM Jr: Role of BCL-2 in the survival and function of developing and mature sympathetic neurons. Neuron 1995, 15:649-661.
22. Troy CM, Stefanis L, Prochiantz A, Greene LA, Shelanski ML: The contrasting roles of ICE family proteases and interleukin-1β in apoptosis induced by trophic factor withdrawal and by copper/zinc superoxide dismutase down-regulation. Proc Natl Acad Sci U S A 1996, 93:5635-5640. In PC-12 cells, loss of SOD1 activity and withdrawal of trophic factors appeared to induce apoptosis through pathways using different interleukin 1β converting enzyme-family enzymes or different substrates for these enzymes.
23. 2 levels delayed onset of apoptosis.
24. Rabizadeh S, Gralla EB, Borchelt DR, Gwinn R, Valentine JS, Sisodia S, Wong P, Lee M, Hahn H, Bredesen DE: Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc Natl Acad Sci U S A 1995, 92:3024-3028. In a neuronal cell line, expression of a transgene for wild-type SOD1 reduced apoptotic death triggered by serum withdrawal and calcium ionophores; in contrast, expression of a transgene for mutant SOD1 augmented apoptosis
25. Troy CM, Derossi D, Prochiantz A, Greene LA, Shelanski MI: Downregulation of Cu/Zn superoxide dismutase leads to cell death via the nitric oxide-peroxynitrite pathway. J Neurosci 1996, 16:253-261.
26. Patel M, Day BJ, Crapo JD, Fridovich I, McNamara JO: Requirement for superoxide in excitotoxic cell death. Neuron 1996, 16:345-355.
27. Clément MV, Stamenkovic I: Superoxide anion is a natural inhibitor of Fas-mediated cell death. EMBO J 1996, 15:216-225.
28. Pardo CA, Xu Z, Borchelt DR, Price DL, Sisodia SS, Cleveland DW: Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons Proc Nat Acad Sci U S A 1995, 92:954-958.
29. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng H-X, et al.: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59-62.
30. Borchelt DR, Lee MK, Slunt HS, Guarnieri M, Xu ZS, Wong PC, Brown RHJ, Price DL, Sisodia SS, Cleveland DW: Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci U S A 1994, 91:8292-8296.
31. m for hydrogen peroxide. Proc Natl Acad Sci U S A 1996, 93:5709-5714. The authors reported that mutant SOD1 augmented peroxidase activity, as detected by a decrease in the Michaelis-Menton constant for the peroxidase reaction; this might reflect greater ease of access of hydrogen peroxide to the active site in the mutant protein.
32. Deng H-X, Hentati A, Tainer JA, Iqbal Z, Cayabyab A, Hung W-Y, Getzoff ED, Hu P, Herzfeldt B, Roos RP etal.: Amyotrophic lateral sclerosis and structural defects in Cu,ZN superoxide dismustase. Science 1993, 261:1047-1051.
33. Beckman JS, Carson M, Smith CD, Kuppenol WH: ALS, SOD, and peroxynitrite [Letter]. Nature 1993: 364:584.
34. Boulanos J, Heales S, Land J, Clark J: Effect of peroxynitrite on the mitochondrial respiratory chain, differential susceptibility of neurones and astrocytes in primary culture. J Neurochem 1995, 64:1965-1972.
35. Epstein CJ, Avraham KB, Lovett M, Smith S, Elroy-Stein O, Rotman G, Bry C, Groner Y: Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome Proc Natl Acad Sci U S A 1987, 84:8044-8048.
36. Dal Canto MC, Gurney ME: Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS). Brain Res 1995, 676:25-40.
37. Reaume AG, Elliott JL, Hoffman EK, Kowall NW, Ferrante RJ, Siwek DF, Wilcox HM, Flood DG, Seal MF, Brown RH Jr, et al. WD, Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nature Genet 1996: 13:43-47. Mice devoid of cytosolic SOD1 activity showed normal motor behavior and normal numbers of motor neurons at 4 months of age.
38. Li Y, Huang T-T, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, Yoshimura MP, Berger C, Chan PH, Wallace DC, Epstein CJ: Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nature Genet 1995, 11:376-381. Mice devoid of mitochondrial SOD (SOD2) died shortly after birth.
39. Tu PH, Raju P, Robinson KA, Gurney ME, Trojanowski JQ, Lee VM: Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc Natl Acad Sci U S A 1996, 93:3155-3160.
40. Mourelatos Z, Gonatas NK, Stieber A, Gurney ME, Dal Canto MC: The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease. Proc Natl Acad Sci U S A 1996, 93:5472-5477.
41. Wong PC, Borchelt DR: Motor neuron disease caused by mutations in superoxide dismutase 1. Curr Opm Neurol 1995, 8:294-301.
42. Chiu AY, Zhai P, Dal Canto MC, Peters TM, Kwon YW, Prattis SM, Gurney ME: Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol Cell Neurosci 1995, 6:349-362.
43. Ripps ME, Huntley GW, Hof PR, Morrison JH, Gordon JW: Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 1995, 92:689-693.
44. Gurney M, Cutting F, Zhai P, Doble A, Taylor C, Andrus P, Hall E: Benefit of Vitamin E, riluzole and gabapentin in a transgenic model of familial ALS. Ann Neurol 1996, 39:147-158. In transgenic ALS mice, onset of motor neuron pathology, but not its rate of progression, was slowed by Vitamin E. The reciprocal situation was true for therapy with the anti-glutamate agent riluzole, suggesting that different biochemical events might underlie the initiation and the propagation of the motor neuron death process.
45. Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, Sisodia SS, Cleveland DW, Price DL: An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995, 14:1105-1116.
46. Lee MK, Cleveland DW: A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease. Neuron 1994, 13:975-988.
47. Figlewicz DA, Krizus A, Martinoli MG, Meininger V, Dib M, Rouleau GA, Julien J-P: Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet 1994: 3:1757-1761.
48. Dykens JA: Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated calcium and sodium: implications for neurodegeneration J Neurochem 1993, 63:584-591.
49. Beal M: Aging, energy, and oxidative stress in neurodegenerative diseases [Review]. Ann Neurol 1995, 38:357-366.